[1]曾 翔,文 星,常一航,等.营养风险筛查和BMI在克罗恩病患者营养评估中的应用[J].医学信息,2019,32(08):133-135.[doi:10.3969/j.issn.1006-1959.2019.08.039]
　ZENG Xiang,WEN Xing,CHANG Yi-hang,et al.Application of Nutritional Risk Screening and BMI in Nutritional Assessment of Patients with Crohn's Disease[J].Journal of Medical Information,2019,32(08):133-135.[doi:10.3969/j.issn.1006-1959.2019.08.039]
点击复制

营养风险筛查和BMI在克罗恩病患者营养评估中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年08期
页码:
133-135
栏目:
临床研究
出版日期:
2019-04-15

文章信息/Info

Title:
Application of Nutritional Risk Screening and BMI in Nutritional Assessment of Patients with Crohn's Disease
文章编号:
1006-1959（2019）08-0133-03
作者:
曾 翔; 文 星; 常一航; 沈 金; 唐 华
（重庆医科大学附属第一医院胃肠外科，重庆 400016）
Author(s):
ZENG Xiang; WEN Xing; CHANG Yi-hang; SHEN Jin; TANG Hua
(Department of Gastroenterology,the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016,China)
关键词:
克罗恩病; 营养风险筛查（NRS-2002）; BMI; 营养评估
Keywords:
Crohn's disease; Nutritional risk screening (NRS-2002); BMI; Nutritional assessment
分类号:
R574.62
DOI:
10.3969/j.issn.1006-1959.2019.08.039
文献标志码:
A
摘要:
目的 运用营养风险筛查（NRS-2002）和体重指数（BMI）评估克罗恩病患者的营养状况。方法 选取2014年9月~2018年5月重庆医科大学附属第一医院胃肠外科收治的43例克罗恩病患者作为研究对象。运用NRS-2002和BMI对全组患者进行营养状况评估，比较克罗恩病合并肠皮瘘患者和非肠皮瘘患者的营养筛查评分、BMI及血红蛋白计数。结果 43例患者营养风险评分≥3分者21例，发生率48.84%；BMI＜18.5 kg/m2者9例，发生率20.93%。合并肠皮瘘患者营养风险评分≥3分者9例，发生率81.81%；BMI＜18.5 kg/m2者6例，发生率54.55%。非肠皮瘘患者营养风险评分≥3分者12例，发生率37.50%；BMI＜18.5 kg/m2者3例，发生率9.38%。合并肠皮瘘患者营养风险和营养不良的发生率分别为81.81%和37.50%，高于非肠皮瘘患者的54.55%和9.38%，差异有统计学意义（P＜0.05）。43例患者中发生贫血23例，其中合并肠皮瘘7例，非肠皮瘘患者16例，非肠皮瘘患者及肠皮瘘患者之间无统计学差异（P＞0.05）。结论 克罗恩病患者营养风险和营养不良发生率高，克罗恩病合并肠皮瘘患者较非肠皮瘘患者具有更高的营养风险和营养不良发生率。因此应加强围手术期克罗恩病患者的营养支持治疗，尤其是合并肠皮瘘患者。
Abstract:
Objective To assess the nutritional status of patients with Crohn's disease using nutritional risk screening (NRS-2002) and body mass index (BMI). Methods 43 patients with Crohn's disease admitted to the First Affiliated Hospital of Chongqing Medical University from September 2014 to May 2018 were selected as subjects. NRS-2002 and BMI were used to evaluate the nutritional status of the whole group of patients, and the nutritional screening scores, BMI and hemoglobin counts of Crohn's disease patients with intestinal fistula and non-intestinal fistula were compared. Results 43 patients with nutritional risk score ≥3 were enrolled in 21 patients, the incidence rate was 48.84%; 9 patients with BMI <18.5 kg/m2, the incidence rate was 20.93%. In patients with intestinal sputum, the nutritional risk score was ≥3 points in 9 cases, the incidence rate was 81.81%; BMI <18.5 kg/m2 in 6 cases, the incidence rate was 54.55%. In patients with non-intestinal fistula, 12 patients had a nutritional risk score of ≥3, the incidence rate was 37.50%; 3 patients with BMI <18.5 kg/m2, the incidence rate was 9.38%. The incidence of nutritional risk and malnutrition in patients with intestinal fistula was 81.81% and 37.50%, respectively, which was higher than that of non-intestinal fistula patients (54.55% and 9.38%),the difference was statistically significant (P<0.05). Of the 43 patients, 23 had anemia, including 7 patients with intestinal fistula and 16 patients with non-intestinal fistula. There was no significant difference between patients with non-intestinal fistula and patients with intestinal fistula (P>0.05).Conclusion Patients with Crohn's disease have a high incidence of nutritional risk and malnutrition. Patients with Crohn's disease and intestinal fistula have higher nutritional risk and malnutrition rate than patients with non-intestinal fistula. Therefore, nutritional support for patients with Crohn's disease during perioperative period should be strengthened, especially in patients with intestinal fistula.

参考文献/References:

[1]Atreja A,Aggarwal A,Dwivedi S,et al.Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn's disease strictures[J].J Crohns Colitis,2014,8(5):392-400. [2]中华医学会消化病学分会炎症性肠病协作组.对我国炎症性肠病诊断治疗规范的共识意见[J].胃肠病学,2007,12(8):488-495． [3]Harvey SE,Parrott F,Harrison DA,et al.Trial of the route of early nutritional support in critically ill adults[J].N Engl J Med,2014,371(18):1673-1684. [4]Fobes A,Escher J,Hebuterne X,et al.ESPEN guideline:Clinical nutrition in inflammatory bowel disease[J].Clin Nutr,2017,36(2):321-347. [5]Buchman AL,Scolapio J,Fryer J.AGA technical review on short bowel syndrome and intestinal transplantation[J].Gastroenterology,2003,124(4):1111-1134. [6]吴卫卫,汪健,黄顺根.肠外营养导致大鼠肝细胞炎性因子及受体基因表达的变化及临床意义[J].临床小儿外科杂志,2011, 10(2):87-89. [7]Heerasing N,Thompson B,Hendy P,et al.Exclusive enteral nutrition proivdes an effective bridge to safer interval elective surgery for adults with Crohn`s disease[J].Aliment Pharmacol Ther,2017,45(5):660-669. [8]Brennan GT,Ha I,Hogan C,et al.Does preoperative enteral or parenteral nutrition reduce postoperative complications in Crohn's disease patients: a meta-analysis[J].Eur J Gastroenterol Hepatol,2018,30(9):997-1002. [9]张元贤,唐兰,王小林,等.重庆市成人居民贫血现状调查[J].重庆医科大学学报,2011,36(3):381-383. [10]Peyrin-Biroulet L,Lopez A,Cummings JRF,et al.Review article:treating-to-target for inflammatory bowel disease-associated anaemia[J].Aliment Pharmacol Ther,2018,48(6):610-617.

相似文献/References:

[1]王莹洁,戴迟兵.益生菌在炎症性肠病中的应用研究[J].医学信息,2020,33(22):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
　WANG Ying-jie,DAI Chi-bing.Study on the Application of Probiotics in Inflammatory Bowel Disease[J].Journal of Medical Information,2020,33(08):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
[2]郑鑫辉,崔慧丽,杨铁毅,等.粪乳铁蛋白、维生素D水平与克罗恩病患者骨质疏松的相关性[J].医学信息,2021,34(05):114.[doi:10.3969/j.issn.1006-1959.2021.05.032]
　ZHENG Xin-hui,CUI Hui-li,YANG Tie-yi,et al.Correlation Between Fecal Lactoferrin,Vitamin D Levels and Osteoporosis in Crohn’s Disease[J].Journal of Medical Information,2021,34(08):114.[doi:10.3969/j.issn.1006-1959.2021.05.032]
[3]郑鑫辉,崔慧丽,邵 进,等.克罗恩病患者骨质疏松症的影响因素分析[J].医学信息,2021,34(08):68.[doi:10.3969/j.issn.1006-1959.2021.08.018]
　ZHENG Xin-hui,CUI Hui-li,SHAO Jin,et al.Analysis of Influencing Factors of Osteoporosis in Patients with Crohn’s Disease[J].Journal of Medical Information,2021,34(08):68.[doi:10.3969/j.issn.1006-1959.2021.08.018]
[4]马靖琳,王 婷,肖红斌,等.基于公共数据库分析FOXM1在软组织肉瘤中的表达及临床预后意义[J].医学信息,2024,37(01):1.[doi:10.3969/j.issn.1006-1959.2024.01.001]
　MA Jing-lin,WANG Ting,XIAO Hong-bin,et al.Expression and Prognostic Significance of FOXM1 Gene in Soft Tissue Sarcomas Based on the Public Database[J].Journal of Medical Information,2024,37(08):1.[doi:10.3969/j.issn.1006-1959.2024.01.001]
[5]黄晓东,黄 衔,梁靖华,等.基于m6A相关长链非编码RNA鉴定克罗恩病的潜在诊断生物标志物[J].医学信息,2024,37(01):10.[doi:10.3969/j.issn.1006-1959.2024.01.002]
　HUANG Xiao-dong,HUANG Xian,LIANG Jing-hua,et al.Identification of Potential Diagnostic Biomarkers for Crohn’s Disease Based on m6A-related Long Non-coding RNAs[J].Journal of Medical Information,2024,37(08):10.[doi:10.3969/j.issn.1006-1959.2024.01.002]

更新日期/Last Update: 2019-04-15